The findings could be of special interest for childhood-obesity-induced GBM, as targeting MEX3A as a novel molecular approach can regulate the cytokine production from the adipocytes and immunocytes to prevent the development or progression of GBM in children [133]. The gene discussed is MEX3A; the disease is obesity due to melanocortin 4 receptor deficiency.